🇺🇸 Short selling in United States, Q3 2023

From 14 Jul 2023 to 29 Sep 2023, 4,581 United States companies carried disclosed short positions. The quarter's highest single reading was Novavax, Inc. at 47.13% on 15 Sep 2023. 61 companies appeared in the data for the first time. 131 left it. Figures are disclosed positions from official FINRA data.

← Q2 2023 Q4 2023 →

Cite this page

Plain

Short position data for Short selling in United States, Q3 2023: FINRA, compiled by howshorted.com, settlement date 29 Sep 2023. https://howshorted.com/us/review/2023-q3/

Wikipedia

<ref>{{cite web |title=Short selling in United States, Q3 2023 short position data |url=https://howshorted.com/us/review/2023-q3/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2023-09-29 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-united-states-q3-2023-2023-09-29,
  title        = {Short selling in United States, Q3 2023 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/review/2023-q3/}},
  note         = {Data: FINRA, settlement date 29 Sep 2023; accessed 2026-10-13},
  year         = {2023}
}

Biggest rises of the quarter

Edible Garden AG Incorporated+31.69pp to 32.41%
Femasys Inc.+30.95pp to 30.98%
NanoString Technologies, Inc.+14.63pp to 29.15%
2seventy bio, Inc.+12.32pp to 30.15%
FORUM MARKETS Inc+11.32pp to 11.89%

Biggest falls of the quarter

BioXcel Therapeutics, Inc.−17.68pp to 12.22%
Fate Therapeutics, Inc.−10.98pp to 15.12%
ZyVersa Therapeutics, Inc.−9.66pp to 3.11%
NAPCO SECURITY TECHNOLOGIES, INC−9.29pp to 6.56%
89bio, Inc.−8.92pp to 8.38%

Changes compare each company's last figure of the quarter with its first; companies with a single report in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.